MATINAS BIOPHARMA HOLDINGS, INC. Marketable Securities
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Marketable Securities of $0 as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2026-03-31
- 2025-12-31: Marketable Securities $0.00.
- 2024-12-31: Marketable Securities $0.00.
- 2023-03-31: Marketable Securities $19.12M.
- 2022-12-31: Marketable Securities $21.93M.
| Period end | Marketable Securities |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 |
| 2023-03-31 | $19.12M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $21.93M 10-Q · filed 2023-11-08 |
| 2022-09-30 | $21.88M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $28.10M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $24.54M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $28.59M 10-K · filed 2023-03-15 |
| 2021-09-30 | $28.91M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $29.49M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $37.28M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $46.25M 10-K/A · filed 2022-03-11 |
| 2020-09-30 | $55.72K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $53.05K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $61.09K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $5.10M 10-K · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |